Mueller-Schoell, A.; Klopp-Schulze, L.; Michelet, R.; van Dyk, M.; Mürdter, T.E.; Schwab, M.; Joerger, M.; Huisinga, W.; Mikus, G.; Kloft, C.
Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies. Pharmaceuticals 2021, 14, 115.
https://doi.org/10.3390/ph14020115
AMA Style
Mueller-Schoell A, Klopp-Schulze L, Michelet R, van Dyk M, Mürdter TE, Schwab M, Joerger M, Huisinga W, Mikus G, Kloft C.
Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies. Pharmaceuticals. 2021; 14(2):115.
https://doi.org/10.3390/ph14020115
Chicago/Turabian Style
Mueller-Schoell, Anna, Lena Klopp-Schulze, Robin Michelet, Madelé van Dyk, Thomas E. Mürdter, Matthias Schwab, Markus Joerger, Wilhelm Huisinga, Gerd Mikus, and Charlotte Kloft.
2021. "Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies" Pharmaceuticals 14, no. 2: 115.
https://doi.org/10.3390/ph14020115
APA Style
Mueller-Schoell, A., Klopp-Schulze, L., Michelet, R., van Dyk, M., Mürdter, T. E., Schwab, M., Joerger, M., Huisinga, W., Mikus, G., & Kloft, C.
(2021). Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies. Pharmaceuticals, 14(2), 115.
https://doi.org/10.3390/ph14020115